Last checked at 
| Monday 22 November | |
| Allergy Therapeutics PLC | AGM |
| Crystal Amber Fund Ltd | AGM |
| Mila Resources PLC | GM re placing, subscription and buy of Kathleen Valley stake |
| Mountview Estates PLC | GM re director re-appointments |
| Norish PLC | EGM re name change, share subdivision and change in articles of association |
| Tuesday 23 November | |
| JKX Oil & Gas PLC | EGM re delisting |
| JPMorgan UK Smaller Cos Investment Trust PLC | AGM |
| Orient Telecoms PLC | AGM |
| Physiomics PLC | AGM |
| PZ Cussons PLC | AGM |
| Scancell Holdings PLC | AGM |
| Transense Technologies PLC | AGM |
| Wednesday 24 November | |
| Clinigen Group PLC | AGM |
| CVS Group PLC | AGM |
| Darktrace PLC | AGM |
| European Metals Holdings Ltd | AGM |
| Genus PLC | AGM |
| MGC Pharmaceuticals Ltd | AGM |
| Norish PLC | GM re capital return payment |
| Oxford Cannabinoid Technologies Holdings PLC | AGM |
| Prairie Mining Ltd | AGM |
| Renishaw PLC | AGM |
| Supermarket Income REIT PLC | AGM |
| Tlou Energy Ltd | AGM |
| Thursday 25 November | |
| DX Group PLC | AGM |
| Hammerson PLC | GM re enhanced scrip dividend alternative |
| Hotel Chocolat Group PLC | AGM |
| JPMorgan Global Emerging Markets Income Trust PLC | AGM |
| Origin Enterprises PLC | AGM |
| Pan African Resources Plc | AGM |
| Quiz PLC | AGM |
| Friday 26 November | |
| Base Resources Ltd | AGM |
| Future Metals NL | AGM |
| Greencoat UK Wind PLC | GM re proposal of new ordinary shares |
| JD Sports Fashion PLC | GM re share sub-division |
| Oilex Ltd | AGM |
| Oncimmune Holdings PLC | AGM |
| Quadrise Fuels International PLC | AGM |
| Salt Lake Potash Ltd | AGM |
| ScS Group PLC | AGM |
| Sylvania Platinum Ltd | AGM |
| Copyright 2021 Alliance News Limited. All Rights Reserved. | |
28 Feb 2022 14:41
Oncimmune signs new contract with Alphabet division Verily
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the signing of a new commercial contract with Verily Life Sciences on Monday, a member of Google owner Alphabet's stable, focusing on the autoantibody profiling of patients who had Covid-19 and gone on to develop long lasting symptoms for more than four weeks, or 'long Covid'.
Read more